R92.321
Mammographic fibroglandular density, right breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Mammographic fibroglandular density refers to the amount of fibrous and glandular tissue in the breast as seen on a mammogram. When this density is noted in the right breast under the ICD-10 code R92.321, it indicates that the breast has a higher proportion of dense tissue, which can affect mammogram readings and breast health assessments. This condition is common and varies among women, often influenced by age, hormonal factors, and genetics. Understanding what dense breast tissue means can help women interpret their mammogram results and discuss appropriate screening strategies with their healthcare providers.
Causes & Symptoms
Clinical Causes: Younger age: breasts tend to be denser in younger women, especially premenopausal women. Hormonal influences: estrogen and other hormones stimulate glandular and fibrous tissue growth. Genetics: some women inherit denser breast tissue patterns. Pregnancy and breastfeeding: hormonal changes during these periods can increase breast density. Certain medications: hormone therapy and other drugs may influence tissue composition.
Key Symptoms: Typically no noticeable symptoms; breast density is usually detected through imaging. Dense tissue may obscure tumors or other abnormalities on mammograms, making detection harder.
Diagnostic & Treatment
Diagnosis Path: Mammography is the primary method for assessing breast density. During a mammogram, radiologists evaluate the proportion of dense tissue versus fatty tissue in the breasts. Dense tissue appears white on the mammogram, which contrasts with the darker appearance of fatty tissue. The designation 'fibroglandular density' indicates a predominantly dense pattern, described as heterogeneously dense or extremely dense, depending on extent. Additional imaging techniques like ultrasound or MRI can complement mammography if needed for further assessment.
Treatment Protocols: There is no treatment required solely for dense breast tissue, as it is a normal variation in breast anatomy. However, understanding breast density can influence screening strategies. Women with dense breasts may benefit from supplemental imaging to improve cancer detection. Healthcare providers may advise on personalized screening plans based on density, family history, and risk factors. Maintaining a healthy lifestyle and regular screening are essential components of breast health management.
Clinical Advice & FAQs
Billing Guidance
Is R92.321 a billable ICD-10 code?
Yes, R92.321 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R92.321?
Clinical documentation must specify the nature of Mammographic fibroglandular density, right breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference